Used with full medical evaluation to personalize care
Le mdicament qui utilise cette molcule a t approuv sous le nom Exnatide pour le traitement du diabte de type 2 par la FDA en 2005 et par Sant Canada en 2007
syEx1252 ( gpa6 ::GCaMP3, pha1 ::PHA1)] was generated by crossing ZAS423 with PR675[ tax6 ( p675 )], which yields the genotype azrIs423 ( odr7 p::Chrimson::SL2::mCherry
It is a relatively uncommon condition, with an estimated occurrence of 2 to 10 cases per 100,000 individuals annually
Digestive symptoms such as nausea, bloating, constipation, diarrhea, and mild stomach discomfort are the most common
Neonatal blood carnitine concentrations: normative data by electrospray tandem mass spectrometry